Huai‐Ching Tai
Papers
1
Total Citations
6
H-Index
1
About
Dr. Huai‐Ching Tai is a leading urologic oncologist whose research focuses on advancing surgical treatments for prostate cancer, particularly through minimally invasive techniques. His major contributions center on demonstrating the oncologic effectiveness of laparoscopic radical prostatectomy (LRP) monotherapy for selected men with high-risk prostate cancer. In his pivotal 2013 study, Dr. Tai showed that LRP alone can be a viable, aggressive yet less invasive option for patients with only one D'Amico risk factor, challenging the conventional reliance on multimodal therapy. This work, cited 6 times, provides critical evidence for personalizing treatment in Asian populations. Dr. Tai’s research has helped refine risk stratification, showing that not all high-risk patients require adjuvant radiation or hormone therapy, thereby reducing overtreatment. His findings from a large Asian tertiary referral center have influenced clinical guidelines and surgical decision-making, underscoring the importance of tailored, risk-adapted approaches. By integrating oncologic rigor with surgical innovation, Dr. Tai continues to shape the landscape of prostate cancer management, offering patients more precise and less invasive options.
Research Focus
Key Achievements
Top Papers
- 1